SCOTT HEINZ: Open Payments
NPI 1194500645 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 60 payments from 19 companies in 2025. Trend: 2023 $237 · 2024 $1,688 · 2025 $1,283
Food & beverage: $1,283
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $242 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $181 |
| ABBVIE INC. | 8 | $156 |
| Lilly USA, LLC | 9 | $151 |
| Exact Sciences Corporation | 3 | $78 |
| Amgen Inc. | 4 | $68 |
| Corcept Therapeutics | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 1 | $54 |
| Inspire Medical Systems, Inc. | 2 | $48 |
Products named: Kerendia, Wegovy, MOUNJARO, QULIPTA, Korlym, JARDIANCE, VOQUEZNA, Ozempic.
Industry payments across FL — which companies pay providers there.
